Loading…
This closeout letter addressed Dual Health Body and Mind's corrective actions following an initial warning issued in May 2018 regarding dietary supplements. The company had been cited for violations related to unapproved new drug claims, misbranding, and adulteration. The April 2021 closeout letter indicated that the firm had adequately addressed the original violations, though the FDA reserved the right to conduct future inspections and take additional regulatory action if compliance lapses were discovered.